Skip to main content

CITADEL ADVISORS LLC

Position in NPCE — NeuroPace Inc

CIK 1423053 MIAMI, FL

Position in NPCE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,046,632
+$898,848 QoQ
Shares Held
128,800
+47.6% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 112 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NPCE Over Time

Shares Held

Position Value (USD)

Derivatives in NPCE

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$225,789
PutShares
21,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,441,341,341 across 94 Medical Devices names. NPCE ranks #43 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NPCE

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,046,632 128,800
2026-03-31 $1,147,784 87,284
2025-12-31 $2,035,902 131,859
2025-09-30 $225,789 21,900
2025-06-30 $430,004 38,600
2025-06-30 $115,856 10,400
2025-03-31 $3,687 300
2025-03-31 $1,515,921 123,346
2025-03-31 $22,122 1,800
2024-12-31 $432,012 38,607
2024-12-31 $11,190 1,000
2024-12-31 $8,952 800
2024-09-30 $9,061 1,300
2024-09-30 $697 100
2024-09-30 $114,872 16,481
2024-06-30 $63,504 8,400
2024-06-30 $2,268 300
2024-06-30 $280,565 37,112
2024-03-31 $66,000 5,000
2024-03-31 $107,580 8,150
2024-03-31 $99,000 7,500
2023-12-31 $248,006 24,055
2022-06-30 $107,375 21,692
2021-12-31 $100,890 10,009
2021-09-30 $409,278 25,822